# Junta clínica — PT-pseudo_2ef22b5dd08e (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_2ef22b5dd08e",
  "pid": "PT-pseudo_2ef22b5dd08e",
  "task": 1,
  "psa": 9.3,
  "age": 66,
  "months": 2,
  "pirads": "4",
  "psad": 0.296,
  "psav": 1.34,
  "psap": 6.2,
  "vol": 31.46,
  "dre": "Normal",
  "bx": "None",
  "cspca": 0.8335312,
  "medhx": "Not reported",
  "meds": "None",
  "notes": "PSA 9.3 ng/mL. PI-RADS 4. PSAD 0.30. Prostate volume 31 mL. csPCa 0.83.",
  "pmhx": [],
  "allergies": [],
  "vitals": {
    "weight": "75 kg",
    "height": "184 cm",
    "bmi": "22.2",
    "bp": "136/76 mmHg",
    "hr": "71 bpm",
    "smoking": "Ex-smoker (24 pack-yr, quit 2020)",
    "last_dental": "6 mo ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "18 Feb 2025",
  "enc_ref": "Dr. C. Peters (GP)",
  "enc_type": "Follow-up - PSA + MRI",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical reassessment indicated due to a persistent upward PSA trajectory coupled with recent multiparametric magnetic resonance imaging results."
    },
    {
      "s": "History",
      "t": "At 66 years of age, this semi-retired harbour pilot seeks review concerning his prostate-specific antigen trajectory, accompanied by a longstanding record of moderate lower urinary tract symptoms (IPSS 8/35). He shares an assisted-living residence with his spouse, who serves as his main point of contact. Physical activity remains a priority, featuring three weekly cycling sessions covering roughly 30 km each, balanced with an alcohol intake of 8 units weekly. His smoking history totals 24 pack-years, though he ceased tobacco use in 2020. Ocular limitations necessitate large-print documents. Recent medical engagements include a gastroenterology visit for standard colonoscopy screening, pulmonary function testing, and a baseline chest radiograph. A laparoscopic gallbladder removal occurred in 2015, entirely separate from his present urological evaluation. He maintains no active comorbidities, takes no prescribed medications, manages occasional seasonal allergies with non-prescription antihistamines, and carries no prior biopsy history. No unexplained weight reduction, skeletal discomfort, or blood in the urine has been reported. General health otherwise appears stable."
    },
    {
      "s": "Physical examination",
      "t": "Per rectum: Normal DRE; digital assessment reveals a uniformly enlarged gland exhibiting consistent firmness without discrete irregularities or lateralised masses. Cardiovascular and respiratory auscultation demonstrate regular rhythms and clear field expansion. Abdominal percussion and palpation confirm a pliable, non-tender cavity lacking palpable hepatosplenomegaly or abnormal growths."
    }
  ],
  "occupation": "harbour pilot (semi-retired)",
  "marital": "Married",
  "living": "Lives in assisted-living facility",
  "next_of_kin": "Spouse / partner (primary contact)",
  "recent_other": [
    "Gastroenterology — surveillance colonoscopy",
    "Radiology — chest X-ray (routine)",
    "Pulmonary function test — known COPD follow-up"
  ],
  "alcohol": "8 units / week",
  "exercise": "Cycling 3x/week, ~30 km",
  "ipss": "IPSS score: 8/35 (moderate LUTS)",
  "admin": "Visual impairment: large-print correspondence requested.",
  "mri_hospital": "Radboudumc",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_2ef22b5dd08e
Task: 1

Encounter: Urology - outpatient on 18 Feb 2025.
Referrer: Dr. C. Peters (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 66-year-old male
  - PSA: 9.3 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.296 ng/mL²
  - PSA velocity: 1.34 ng/mL/yr
  - Prior PSA: 6.2 ng/mL
  - Prostate volume: 31.46 mL
  - Months since last PSA: 2
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.8335312 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 9.3 ng/mL. PI-RADS 4. PSAD 0.30. Prostate volume 31 mL. csPCa 0.83.

Vitals: weight 75 kg, height 184 cm, BMI 22.2, BP 136/76 mmHg, HR 71 bpm. Smoking: Ex-smoker (24 pack-yr, quit 2020).

Chief complaint: Clinical reassessment indicated due to a persistent upward PSA trajectory coupled with recent multiparametric magnetic resonance imaging results.

History: At 66 years of age, this semi-retired harbour pilot seeks review concerning his prostate-specific antigen trajectory, accompanied by a longstanding record of moderate lower urinary tract symptoms (IPSS 8/35). He shares an assisted-living residence with his spouse, who serves as his main point of contact. Physical activity remains a priority, featuring three weekly cycling sessions covering roughly 30 km each, balanced with an alcohol intake of 8 units weekly. His smoking history totals 24 pack-years, though he ceased tobacco use in 2020. Ocular limitations necessitate large-print documents. Recent medical engagements include a gastroenterology visit for standard colonoscopy screening, pulmonary function testing, and a baseline chest radiograph. A laparoscopic gallbladder removal occurred in 2015, entirely separate from his present urological evaluation. He maintains no active comorbidities, takes no prescribed medications, manages occasional seasonal allergies with non-prescription antihistamines, and carries no prior biopsy history. No unexplained weight reduction, skeletal discomfort, or blood in the urine has been reported. General health otherwise appears stable.

Physical examination: Per rectum: Normal DRE; digital assessment reveals a uniformly enlarged gland exhibiting consistent firmness without discrete irregularities or lateralised masses. Cardiovascular and respiratory auscultation demonstrate regular rhythms and clear field expansion. Abdominal percussion and palpation confirm a pliable, non-tender cavity lacking palpable hepatosplenomegaly or abnormal growths.

Patient info: harbour pilot (semi-retired); Married; Lives in assisted-living facility.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 8 units / week; exercise Cycling 3x/week, ~30 km; IPSS score: 8/35 (moderate LUTS).

Recent other appointments: Gastroenterology — surveillance colonoscopy; Radiology — chest X-ray (routine); Pulmonary function test — known COPD follow-up.
Admin: Visual impairment: large-print correspondence requested.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.90
  uncertainty  +/- 0.05 epistemic (95% band 0.80-0.99); among patients I cannot tell apart the outcome was 0.48 of 1.00 mixed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

What moved me most, across the labelled series: prior positive biopsy, PI-RADS >= 4, no prior biopsy, pmhx_hypercholesterolaemia, suspicious DRE, number of comorbidities. I read 39 variables, all
from the panel — nothing from the mpMRI prose, the PSA trajectory, the previous notes or the
laboratory. Out-of-fold over 91 labelled cases: AUC 0.758, balanced
accuracy 0.625.

The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: never biopsied. My criterion answers BIOPSY.

The criterion: sample when the mpMRI shows a PI-RADS 3 or higher lesion; defer at PI-RADS 1-2. In the labelled series this criterion matched the reading urologist in 24 of 24 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 24 labelled men in this same situation (None prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 0.00 — IDENTICAL PANEL: this is the same case, already in the labelled series: PI-RADS 4, PSA 9.3, PSAD 0.296, age 66, DRE Normal -> BIOPSY (clear). He wrote: "P4 in 66 year old patient."
  2. distance 1.49: PI-RADS 4, PSA 13.9, PSAD 0.177, age 65, DRE Normal -> BIOPSY (clear). He wrote: "P4 in 65 year old patient"
  3. distance 1.83: PI-RADS NA, PSA 4.5, PSAD 0.095, age 67, DRE Normal -> DEFER (clear). He wrote: "Normal MRI. No biopsy"

PRECEDENT: BIOPSY. The nearest precedent is this very patient, so the library returns what the reading urologist actually did with him. That is a record, not a judgement; out of sample this expert is worth only what the distance is worth.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. This patient is in the labelled series, so what follows is the reading urologist's own trace for him, not a prediction.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.
WHAT HE WEIGHS: psa=important, vol=noted, dre=noted, bx=noted, fh=noted, psad=noted, pirads=decisive, age=important.
HOW SURE HE USUALLY IS: clear.

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines link PI-RADS scores to the decision to biopsy, noting that a threshold of PI-RADS $\ge 3$ is used to trigger biopsy. The guideline also suggests that combining targeted biopsy with perilesional sampling when MRI is positive (i.e., PI-RADS $\ge 4$) can mitigate drawbacks.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
Expert 1's suggestion of biopsy is not decisively settled by the guideline because the guideline focuses on the threshold for triggering a biopsy, not the final decision. Expert 4's focus on the specific documents opened is not settled because the guideline does not dictate which specific documents must be opened, only that the decision must be evidence-based.

WHAT WE STILL NEED
The guideline requires establishing the PSA density value to determine if it falls below the $0.20 \text{ ng/mL/cc}$ threshold, as this is a factor in the recommendation to omit biopsy when MRI is negative and clinical suspicion is low.
The prior biopsy status is known as "None," which is a fact that the guideline makes decisive regarding the need for further investigation.
The PSA value is $9.3 \text{ ng/mL}$, which is a value already on the panel, and the guideline requires this value to be considered in conjunction with the PI-RADS score.
The PI-RADS score is $4$, which is a value already on the panel, and the guideline requires this value to be considered in conjunction with the PSA density.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case strongly suggests biopsy based on the structured panel and cohort data, but we must first establish the PSA density value to fully align with the EAU guideline.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> What is the lesion size and zone of the MRI?
  psa_trend (get_psa_trend) -> What is the trend of the serial PSA values?
  previous_notes (get_previous_notes) -> What is the management context regarding prior biopsy, surveillance protocol, and planned treatment?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. Given the PI-RADS score of 4 and the prior biopsy status of 'None', what is the definitive recommendation based on the EAU guideline?

On the plan itself: Dropped 1 question(s) that asked for a value already printed on the panel: "What is the PSA density value to determine if it falls below the $0.20 ext{ ng/mL/cc}$ threshold?".

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
Subject: Prostate Multiparametric MRI | Date: 15 Feb 2025 | Facility: Radboudumc
The lesion size and zone of the MRI is a "14 mm" lesion in the "left peripheral zone (base-to-mid)".
psa_trend
The trend of the serial PSA values is a decline from "6.7" ng/mL in "Jul 2022" to "9.3" ng/mL in "Feb 2025".
previous_notes
The management context regarding prior biopsy, surveillance protocol, and planned treatment is "Prior biopsy: None", "Surveillance protocol: not recorded", and "Planned treatment: not recorded".

WHAT I DID NOT OPEN
I did not open the laboratory_results or the family-history anamnesis because the required information regarding PSA density and family history was not explicitly requested by the Moderator for the initial set of documents.

WHAT THIS SUPPORTS
Findings that argue FOR sampling this patient now:
PI-RADS score of 4, as per the cohort criterion.
The PSA trend shows an upward trajectory culminating in a current PSA of 9.3 ng/mL.

Findings that argue AGAINST sampling this patient now:
The EAU guideline requires establishing the PSA density value to determine if it falls below the $0.20 \text{ ng/mL/cc}$ threshold.

WHERE THIS LEANS
The evidence strongly points towards biopsy based on the PI-RADS 4 finding and the prior biopsy status of 'None', aligning with the Expert-Structured and Expert-Cohort bids.
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 9.30 ng/mL over 4 points spanning 31 months; velocity +0.94 ng/mL per year; doubling time about 67 months.
PROJECTION at 6 months: 14.6 ng/mL, conformal 95% band 4.2-50.8.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.85
  uncertainty  +/- 0.06 epistemic (95% band 0.74-0.96), of which 0.01 comes from values that had to be imputed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

What moved me most across the labelled series: prior positive biopsy, no prior biopsy, free PSA < 15%, DWI restriction in the report, lesion >= 15 mm in the report, suspicious DRE. Out-of-fold AUC 0.794. I am the only expert that has read the report's wording, and I still cannot see the prior grade or the
surveillance history: those are in the notes, and the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.90  ('firm' tier)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.85  ('firm' tier, fusion_nolab)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=0.97  (identical panel in the series)
  EXPERT-COHORT      BIOPSY  (rule pirads_ge_3)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: identical precedent in the labelled series — carried by EXPERT-LIBRARY.
PANEL ANSWER: BIOPSY. The labelled series contains this exact panel; the library returns the reading urologist's own decision for it. Out of sample this rung never fires.

Confidence the trace model expects here: clear. Weights it expects: psa=important, vol=noted, dre=noted, bx=noted, fh=noted, psad=noted, pirads=decisive, age=important.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents opened—radiology_report, psa_trend, and previous_notes—address the core elements of the moderator's questions regarding the MRI findings, PSA trajectory, and prior biopsy status.

ALIGNMENT WITH THE PANEL
The retrieved evidence, specifically the PI-RADS 4 score and the "Prior biopsy: None" from the previous notes, aligns with the PANEL-PROTOCOL's decision of BIOPSY, which was driven by the EXPERT-LIBRARY precedent.

THE OPEN QUESTIONS, ONE BY ONE
Q1. Given the PI-RADS score of 4 and the prior biopsy status of 'None', what is the definitive recommendation based on the EAU guideline? The EAU guideline requires establishing the PSA density value to determine if it falls below the $0.20 \text{ ng/mL/cc}$ threshold, which was not retrieved.

WHAT CARRIES WEIGHT, AND WHY
The PI-RADS score of 4 is highly relevant as it is a decisive factor in the cohort criterion and the EAU guideline. The prior biopsy status of 'None' is also critical as it dictates the need for further investigation. The PSA trend shows an upward trajectory, which supports the clinical suspicion.

MY SUGGESTION TO THE CHAIR
Based on the strong alignment of the cohort criterion and the expert consensus, I suggest proceeding with a biopsy. The decision is ready to be made, pending the missing PSA density value to fully satisfy the EAU guideline's secondary consideration.

VERDICT: ready | SUGGEST: biopsy | MISSING: laboratory_results

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

Biopsy is recommended because the evidence strongly converged on this decision, driven primarily by the PI-RADS 4 score and the prior biopsy status of 'None'. The cohort criterion and the expert library precedent both supported proceeding with a biopsy in this scenario. The PSA trajectory, showing an upward trend to 9.3 ng/mL, further supported the clinical suspicion, and the verifier confirmed the record was ready for a decision.

What carried weight: psa=important, vol=noted, bx=noted, psad=noted, pirads=decisive, age=important
Documents this conference opened: radiology_report, psa_trend, previous_notes
